Navigation Links
Pharmos Corporation Reports 2009 Third Quarter Results
Date:11/12/2009

t the current cash and cash equivalents, totaling $1.3 million as of September 30, 2009, will be sufficient to support the Company's currently planned continuing operations at least through December 31, 2009. The Company is working on securing cash resources to extend operations beyond December 31, 2009. Cowen and Company have been retained as advisors to help accelerate the process of a partnership arrangement for our lead compound, Dextofisopam. Additionally any proceeds for the sale of the New Jersey NOL's are expected to extend operations beyond December 31, 2009. The Company's expected cash expenditures in the last quarter of 2009 will be less than the first three quarters of 2009 as the Dextofisopam Phase 2b trial completed patient treatment in July and statistical analysis was completed in September 2009. The majority of ongoing costs will be general and administrative which will be significantly less than funding a clinical trial. The Company routinely pursues various funding options, including additional equity offerings, equity-like financing, strategic corporate alliances, business combinations and the establishment of product related research and development limited partnerships, to obtain additional financing to continue the development of its products and bring them to commercial markets. On April 21, 2009, the Company completed a private placement of common stock and warrants. At the closing, the Company issued 18,000,000 shares of common stock and warrants exercisable for an additional 18,000,000 shares of common stock for an aggregate purchase price of $1,800,000. The exercise price of the warrants, which have a five-year term, is $0.12 per share. The details of the financing, made by existing investors and current board members, are described in Note 2 to the financial statements. This financing would also support additional efforts to negotiate a strategic partnership or license arrangement with a pharmaceutical company. This is consistent wit
'/>"/>
SOURCE Pharmos Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Pharmos Issues Business Update on Dextofisopam Trial and Financing
2. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
3. MedCath Corporation Reports Fourth Quarter Earnings
4. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
5. Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
6. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
7. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
8. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
9. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
10. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
11. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 ... their own employees to capture critical product and ... there are many benefits to employee-based studies, it ... to leverage their own internal employees to capture ... recent study by benchmarking firm, Best Practices, LLC, ...
(Date:7/2/2015)... , July 2, 2015  New product launches are ... leading role in educating thought leaders about new products, ... heavily influence how well a new therapy performs at ... from research and consulting leader Best Practices, LLC, critical ... to focus on are early stage thought leader (TL) ...
(Date:7/2/2015)... 2015 Releases of the genetically ... aegypti , , reduced the dengue mosquito population ... by 95%, well below the modelled threshold for ... The journal PLOS Neglected Tropical Diseases published ... engineered mosquitoes. The results showed that in Juazeiro city, ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... TOKYO , March 16 Astellas Pharma Inc. (TSE: 4503) today notified OSI Pharmaceuticals Inc. (Nasdaq: OSIP ) that it will nominate a full and competing slate ... ... ... ...
... MISSISSAUGA, Ontario , March 16 CardioGenics Holdings ... products targeting the Point-Of-Care (POC) segment of the IVD market ... agreement with its chief executive officer, Dr. Yahia Gawad ... 150,000,000 million shares of the Company,s common stock held indirectly ...
Cached Medicine Technology:Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 2Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 3Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 4Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 5Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 6Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 7Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 8Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 9Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 10CardioGenics Announces Lock-Up Agreement with Dr. Yahia Gawad 2CardioGenics Announces Lock-Up Agreement with Dr. Yahia Gawad 3CardioGenics Announces Lock-Up Agreement with Dr. Yahia Gawad 4
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and the ... provide members of the Red Deer community with free fitness training and indoor fitness ... games, food, events and entertainment raised thousands of charity dollars and ended with a ...
(Date:7/2/2015)... Richmond, VA (PRWEB) , ... July 02, 2015 , ... ... New Albany, Mississippi. The opening is the first sweetFrog store located in Mississippi. The ... fastest growing companies in 2014. , The store, located at 104 Railroad Avenue, New ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was ... , The store, which opened July 1 at Duke’s Travel Plaza, is located at:, ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American ... introduction of the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, ... this Act seeks to decrease drug overdose – especially of heroin and opioid ...
(Date:7/2/2015)... Lincoln, RI (PRWEB) , ... July 02, 2015 , ... ... keep safety in mind. That’s why Amica Insurance is sharing some tips ... Safety Commission (CPSC), approximately 230 people go to the emergency room daily with fireworks-related ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2
... ... Free Choice Foundation, an organization of expatriates living in Japan, will exercise ... revision of laws and regulations. They are petitioning for the revision ... April 2010, which will require visa renewal applicants to present proof of ...
... , EDINBURGH, Scotland, September 1 ... has added 25,new staff to its R&D, business development and ... The appointment of key staff is in line with the ... and increasing,its focus on business development and R&D activities. , ...
... A study in the Sept.1 issue of the journal ... of breast cancer patients are impaired during the administration ... of chemotherapy is associated with a temporary disruption of ... progressively worse and more enduring impairments. ...
... , , , NEW ... same music that motivates Madonna? Curious about what "The Remedy" is for ... with a revolutionary approach to having a fit body and a sound ... Sessions offer members the opportunity to download playlists via iTunes from Equinox.com. ...
... ... now reversed decision and will cover patient,s life flight , ... Scottsdale, AZ (PRWEB) August 31, 2009 -- Last year, Sally ... transportation to be evaluated for a liver transplant. Her doctors told her she needed ...
... , , NASHVILLE, Tenn., ... CPIX ) , a specialty pharmaceutical company focused on hospital ... Officer A.J. Kazimi will present at the UBS Global Life ... on Monday, September 21, 2009. Mr. Kazimi will provide an ...
Cached Medicine News:Health News:Free Choice to Petition Japanese Government for Right to Choose Private Health Insurance in Lieu of Japan's Universal Health Care 2Health News:Free Choice to Petition Japanese Government for Right to Choose Private Health Insurance in Lieu of Japan's Universal Health Care 3Health News:Aircraft Reports Material Expansion and Staff Increase 2Health News:Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women 2Health News:Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women 3Health News:Pump Up The Volume: Equinox Releases Exclusive Celebrity Playlists 2Health News:In Final Hour Prior to Litigation, Angel MedFlight's Air Ambulance Team Overturns Decision by Major Insurance Company 2Health News:In Final Hour Prior to Litigation, Angel MedFlight's Air Ambulance Team Overturns Decision by Major Insurance Company 3Health News:Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009 2
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... provide a broad selection of tip ... variety of ophthalmic procedures. Each single ... with a safety cap to lock ... when not in use, and carries ...
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... Probes provide the surgeon with an indirect ... to be easily visualized through the laser ... and light scatter technique, the surgeon can ... flap edge folds, corneal flap striae and ...
Medicine Products: